191 related articles for article (PubMed ID: 28226199)
1. Mortality Risk Factors Among Patients With Cirrhosis and a Low Model for End-Stage Liver Disease Sodium Score (≤15): An Analysis of Liver Transplant Allocation Policy Using Aggregated Electronic Health Record Data.
Atiemo K; Skaro A; Maddur H; Zhao L; Montag S; VanWagner L; Goel S; Kho A; Ho B; Kang R; Holl JL; Abecassis MM; Levitsky J; Ladner DP
Am J Transplant; 2017 Sep; 17(9):2410-2419. PubMed ID: 28226199
[TBL] [Abstract][Full Text] [Related]
2. Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk.
Somsouk M; Kornfield R; Vittinghoff E; Inadomi JM; Biggins SW
Liver Transpl; 2011 Feb; 17(2):129-36. PubMed ID: 21280185
[TBL] [Abstract][Full Text] [Related]
3. Outcomes for liver transplant candidates listed with low model for end-stage liver disease score.
Kwong AJ; Lai JC; Dodge JL; Roberts JP
Liver Transpl; 2015 Nov; 21(11):1403-9. PubMed ID: 26289624
[TBL] [Abstract][Full Text] [Related]
4. Inequity in organ allocation for patients awaiting liver transplantation: Rationale for uncapping the model for end-stage liver disease.
Nadim MK; DiNorcia J; Ji L; Groshen S; Levitsky J; Sung RS; Kim WR; Andreoni K; Mulligan D; Genyk YS
J Hepatol; 2017 Sep; 67(3):517-525. PubMed ID: 28483678
[TBL] [Abstract][Full Text] [Related]
5. Model for end-stage liver disease-sodium underestimates 90-day mortality risk in patients with acute-on-chronic liver failure.
Hernaez R; Liu Y; Kramer JR; Rana A; El-Serag HB; Kanwal F
J Hepatol; 2020 Dec; 73(6):1425-1433. PubMed ID: 32531416
[TBL] [Abstract][Full Text] [Related]
6. Patients With Persistently Low MELD-Na Scores Continue to Be at Risk of Liver-related Death.
Mazumder NR; Atiemo K; Daud A; Kho A; Abecassis M; Levitsky J; Ladner DP
Transplantation; 2020 Jul; 104(7):1413-1418. PubMed ID: 31644488
[TBL] [Abstract][Full Text] [Related]
7. Region 11 MELD Na exception prospective study.
Fisher RA; Heuman DM; Harper AM; Behnke MK; Smith AD; Russo MW; Zacks S; McGillicuddy JW; Eason J; Porayko MK; Northup P; Marvin MR; Hundley J; Nair S
Ann Hepatol; 2012; 11(1):62-7. PubMed ID: 22166562
[TBL] [Abstract][Full Text] [Related]
8. MELD as a metric for survival benefit of liver transplantation.
Luo X; Leanza J; Massie AB; Garonzik-Wang JM; Haugen CE; Gentry SE; Ottmann SE; Segev DL
Am J Transplant; 2018 May; 18(5):1231-1237. PubMed ID: 29316310
[TBL] [Abstract][Full Text] [Related]
9. MELD scores with incorporation of serum sodium and death prediction in cirrhotic patients on the waiting list for liver transplantation: a single center experience in southern Brazil.
Marroni CP; de Mello Brandão AB; Hennigen AW; Marroni C; Zanotelli ML; Cantisani G; Fuchs SC;
Clin Transplant; 2012; 26(4):E395-401. PubMed ID: 22882694
[TBL] [Abstract][Full Text] [Related]
10. Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system.
Genda T; Ichida T; Sakisaka S; Sata M; Tanaka E; Inui A; Egawa H; Umeshita K; Furukawa H; Kawasaki S; Inomata Y
J Gastroenterol; 2014 Feb; 49(2):324-31. PubMed ID: 23478939
[TBL] [Abstract][Full Text] [Related]
11. Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.
Gadiparthi C; Cholankeril G; Yoo ER; Hu M; Wong RJ; Ahmed A
Dig Dis Sci; 2018 Jun; 63(6):1647-1653. PubMed ID: 29611079
[TBL] [Abstract][Full Text] [Related]
12. The Addition of C-Reactive Protein and von Willebrand Factor to Model for End-Stage Liver Disease-Sodium Improves Prediction of Waitlist Mortality.
Starlinger P; Ahn JC; Mullan A; Gyoeri GP; Pereyra D; Alva-Ruiz R; Hackl H; Reiberger T; Trauner M; Santol J; Simbrunner B; Mandorfer M; Berlakovich G; Kamath PS; Heimbach J
Hepatology; 2021 Sep; 74(3):1533-1545. PubMed ID: 33786862
[TBL] [Abstract][Full Text] [Related]
13. Sex Disparity in Liver Transplant and Access to Living Donation.
Karnam RS; Chen S; Xu W; Chen C; Elangainesan P; Ghanekar A; McGilvray I; Reichman T; Sayed B; Selzner M; Sapisochin G; Galvin Z; Hirschfield G; Asrani SK; Selzner N; Cattral M; Lilly L; Bhat M
JAMA Surg; 2021 Nov; 156(11):1010-1017. PubMed ID: 34406347
[TBL] [Abstract][Full Text] [Related]
14. A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list.
Vitale A; Volk ML; De Feo TM; Burra P; Frigo AC; Ramirez Morales R; De Carlis L; Belli L; Colledan M; Fagiuoli S; Rossi G; Andorno E; Baccarani U; Regalia E; Vivarelli M; Donataccio M; Cillo U;
J Hepatol; 2014 Feb; 60(2):290-7. PubMed ID: 24161408
[TBL] [Abstract][Full Text] [Related]
15. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era.
Berg CL; Merion RM; Shearon TH; Olthoff KM; Brown RS; Baker TB; Everson GT; Hong JC; Terrault N; Hayashi PH; Fisher RA; Everhart JE
Hepatology; 2011 Oct; 54(4):1313-21. PubMed ID: 21688284
[TBL] [Abstract][Full Text] [Related]
16. Reduced Access to Liver Transplantation in Women: Role of Height, MELD Exception Scores, and Renal Function Underestimation.
Allen AM; Heimbach JK; Larson JJ; Mara KC; Kim WR; Kamath PS; Therneau TM
Transplantation; 2018 Oct; 102(10):1710-1716. PubMed ID: 29620614
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-to-lymphocyte ratio correlates with proinflammatory neutrophils and predicts death in low model for end-stage liver disease patients with cirrhosis.
Kalra A; Wedd JP; Bambha KM; Gralla J; Golden-Mason L; Collins C; Rosen HR; Biggins SW
Liver Transpl; 2017 Feb; 23(2):155-165. PubMed ID: 28006875
[TBL] [Abstract][Full Text] [Related]
18. The decreasing predictive power of MELD in an era of changing etiology of liver disease.
Godfrey EL; Malik TH; Lai JC; Mindikoglu AL; Galván NTN; Cotton RT; O'Mahony CA; Goss JA; Rana A
Am J Transplant; 2019 Dec; 19(12):3299-3307. PubMed ID: 31394020
[TBL] [Abstract][Full Text] [Related]
19. Defining a Liver Transplant Benefit Threshold for the Model for End-Stage Liver Disease-Sodium Score.
Beal EW; Akateh C; Tumin D; Bagante F; Black SM; Washburn K; Azouley D; Pawlik TM
Exp Clin Transplant; 2020 Aug; 18(4):491-497. PubMed ID: 31050611
[TBL] [Abstract][Full Text] [Related]
20. A model including sarcopenia surpasses the MELD score in predicting waiting list mortality in cirrhotic liver transplant candidates: A competing risk analysis in a national cohort.
van Vugt JLA; Alferink LJM; Buettner S; Gaspersz MP; Bot D; Darwish Murad S; Feshtali S; van Ooijen PMA; Polak WG; Porte RJ; van Hoek B; van den Berg AP; Metselaar HJ; IJzermans JNM
J Hepatol; 2018 Apr; 68(4):707-714. PubMed ID: 29221886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]